Terms: = Brain cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Prognosis
71 results:
1. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
2. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
[TBL] [Abstract] [Full Text] [Related]
3. Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era.
Xie X; Qiu G; Chen Z; Liu T; Yang Y; You Z; Zeng C; Lin X; Xie Z; Qin Y; Wang Y; Ma X; Zhou C; Liu M
Clin Transl Oncol; 2024 Feb; 26(2):434-445. PubMed ID: 37436674
[TBL] [Abstract] [Full Text] [Related]
4. Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma.
Passerini S; Prezioso C; Prota A; Babini G; Bargiacchi L; Bartolini D; Moens U; Antonelli M; Pietropaolo V
J Neurovirol; 2023 Apr; 29(2):232-236. PubMed ID: 37097595
[TBL] [Abstract] [Full Text] [Related]
5. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
[TBL] [Abstract] [Full Text] [Related]
6. Image-based deep learning identifies glioblastoma risk groups with genomic and transcriptomic heterogeneity: a multi-center study.
Yan J; Sun Q; Tan X; Liang C; Bai H; Duan W; Mu T; Guo Y; Qiu Y; Wang W; Yao Q; Pei D; Zhao Y; Liu D; Duan J; Chen S; Sun C; Wang W; Liu Z; Hong X; Wang X; Guo Y; Xu Y; Liu X; Cheng J; Li ZC; Zhang Z
Eur Radiol; 2023 Feb; 33(2):904-914. PubMed ID: 36001125
[TBL] [Abstract] [Full Text] [Related]
7. Histopathology and molecular pathology of pediatric pineal parenchymal tumors.
Vasiljevic A
Childs Nerv Syst; 2023 Sep; 39(9):2273-2284. PubMed ID: 35972537
[TBL] [Abstract] [Full Text] [Related]
8. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
Megyesfalvi Z; Barany N; Lantos A; Valko Z; Pipek O; Lang C; Schwendenwein A; Oberndorfer F; Paku S; Ferencz B; Dezso K; Fillinger J; Lohinai Z; Moldvay J; Galffy G; Szeitz B; Rezeli M; Rivard C; Hirsch FR; Brcic L; Popper H; Kern I; Kovacevic M; Skarda J; Mittak M; Marko-Varga G; Bogos K; Renyi-Vamos F; Hoda MA; Klikovits T; Hoetzenecker K; Schelch K; Laszlo V; Dome B
J Pathol; 2022 Aug; 257(5):674-686. PubMed ID: 35489038
[TBL] [Abstract] [Full Text] [Related]
9. Glioma targeted therapy: insight into future of molecular approaches.
Yang K; Wu Z; Zhang H; Zhang N; Wu W; Wang Z; Dai Z; Zhang X; Zhang L; Peng Y; Ye W; Zeng W; Liu Z; Cheng Q
Mol Cancer; 2022 Feb; 21(1):39. PubMed ID: 35135556
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma.
Sati ISEE; Parhar I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948346
[TBL] [Abstract] [Full Text] [Related]
11. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
[TBL] [Abstract] [Full Text] [Related]
12. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
Liang SK; Hsu CC; Song HL; Huang YC; Kuo CW; Yao X; Li CC; Yang HC; Hung YL; Chao SY; Wu SC; Tsai FR; Chen JK; Liao WN; Cheng SC; Tsou TC; Wang IC
Oncogene; 2021 Jul; 40(30):4847-4858. PubMed ID: 34155349
[TBL] [Abstract] [Full Text] [Related]
13. Dose escalation study of targeted alpha therapy with [
Królicki L; Bruchertseifer F; Kunikowska J; Koziara H; Pawlak D; Kuliński R; Rola R; Merlo A; Morgenstern A
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3595-3605. PubMed ID: 33860346
[TBL] [Abstract] [Full Text] [Related]
14. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion.
Guihurt Santiago J; Burgos-Tirado N; Lafontaine DD; Mendoza Sierra JC; Camacho RH; Vecchini Rodríguez CM; Morales-Tirado V; Flores-Otero J
BMC Cancer; 2021 Jan; 21(1):53. PubMed ID: 33430814
[TBL] [Abstract] [Full Text] [Related]
15. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
[TBL] [Abstract] [Full Text] [Related]
16. p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer.
Bae HJ; Kang SK; Kwon WS; Jeong I; Park S; Kim TS; Kim KH; Kim H; Jeong HC; Chung HC; Rha SY
Biochem Pharmacol; 2021 Jan; 183():114320. PubMed ID: 33161023
[TBL] [Abstract] [Full Text] [Related]
17. Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.
Chung PED; Gendoo DMA; Ghanbari-Azarnier R; Liu JC; Jiang Z; Tsui J; Wang DY; Xiao X; Li B; Dubuc A; Shih D; Remke M; Ho B; Garzia L; Ben-David Y; Kang SG; Croul S; Haibe-Kains B; Huang A; Taylor MD; Zacksenhaus E
Nat Commun; 2020 Apr; 11(1):1825. PubMed ID: 32286280
[TBL] [Abstract] [Full Text] [Related]
18. CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Appay R; Dehais C; Maurage CA; Alentorn A; Carpentier C; Colin C; Ducray F; Escande F; Idbaih A; Kamoun A; Marie Y; Mokhtari K; Tabouret E; Trabelsi N; Uro-Coste E; Delattre JY; Figarella-Branger D;
Neuro Oncol; 2019 Dec; 21(12):1519-1528. PubMed ID: 31832685
[TBL] [Abstract] [Full Text] [Related]
19. The Influence of Distinct Regulatory miRNAs of the p15/p16/rb1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme.
Sippl C; Teping F; Ketter R; Braun L; Tremmel L; Schulz-Schaeffer W; Oertel J; Urbschat S
World Neurosurg; 2019 Dec; 132():e900-e908. PubMed ID: 31351207
[TBL] [Abstract] [Full Text] [Related]
20. Multifunctional nanocapsules on a seesaw balancing sonodynamic and photodynamic therapies against superficial malignant tumors by effective immune-enhancement.
Liu Z; Li J; Jiang Y; Wang D
Biomaterials; 2019 Oct; 218():119251. PubMed ID: 31319284
[TBL] [Abstract] [Full Text] [Related]
[Next]
